CHELMSFORD, Mass., December 3, 2019 – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced David Macdonald, President and CEO of First Light Diagnostics, will be among the presenters at the 2019 New England Venture Summit. The New England Venture Summit is an event that allows…
Chelmsford, MA (November 13, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Melvin P. Weinstein, M.D., to the company’s world-class, international Clinical Advisory Board. “Dr. Weinstein is a recognized expert in infectious disease and antimicrobial susceptibility testing…
Commits to deliver platform to enable targeted treatment at the onset of infection Chelmsford, MA (October 30, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced their participation in the U.S. Centers for Disease Control and Prevention (CDC) Antimicrobial Resistance (AMR)…
Two-day event highlights investment trends and opportunities in Life Sciences Chelmsford, MA (October 16, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced that First Light’s President & CEO, David Macdonald will be among the presenters at the 2019 BIO Investor…
Chelmsford, MA (October 9, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Angela M. Caliendo, M.D., Ph.D., to the company’s world-class, international Clinical Advisory Board. “Angie’s expertise and deep research experience in the development of diagnostic tests…
Our MultiPath benchtop analyzer is advancing the field of rapid diagnostics in several key areas:
If you have been watching the continued growth and development of this exciting company and would like to to speak in person with David Macdonald, CEO, and Don Straus, CSO, please fill out the form below and we will work with you to coordinate a one on one meeting.
